Archean Chemical Q4FY26 Consolidated PAT Slumps to ₹122.3mn; FY26 Revenue Up 8% to ₹11,740.2mn

4 min read     Updated on 13 May 2026, 02:33 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Archean Chemical Industries reported a sharp decline in Q4FY26 consolidated PAT to ₹122.3mn from ₹537.5mn YoY, with EBITDA falling to ₹490.8mn from ₹961.0mn. Full-year FY26 consolidated revenue grew 8% to ₹11,740.2mn, while PAT stood at ₹1,054.1mn versus ₹1,621.4mn in FY25. The company also highlighted a key strategic milestone—the groundbreaking of its SiC-based semiconductor facility in Bhubaneswar, approved under the Indian Semiconductor Mission, with an annual capacity of 60,000 wafers and 96 million packaging units.

powered bylight_fuzz_icon
40106447

*this image is generated using AI for illustrative purposes only.

Archean Chemical Industries reported a steep year-on-year decline in profitability in Q4FY26, even as full-year consolidated revenue posted modest growth. The company's Q4FY26 consolidated net profit (Profit After Tax) fell to ₹122.3mn from ₹537.5mn in Q4FY25, reflecting significant pressure on the bottom line. Consolidated total income for Q4FY26 came in at ₹3,063.3mn, compared to ₹3,533.8mn in the year-ago quarter. For the full year FY26, consolidated total income grew 8% year-on-year to ₹11,740.2mn from ₹10,912.4mn in FY25.

Q4FY26 & FY26 Consolidated Financial Performance

Operational profitability saw a sharp contraction during Q4FY26. Consolidated EBITDA declined to ₹490.8mn from ₹961.0mn on a year-on-year basis. Finance costs rose sharply to ₹104.3mn in Q4FY26 from ₹2.9mn in Q4FY25, weighing heavily on the bottom line. For the full year FY26, consolidated EBITDA stood at ₹2,657.3mn against ₹3,514.4mn in FY25, while consolidated PAT for FY26 was ₹1,054.1mn compared to ₹1,621.4mn in FY25. The following table summarizes the key consolidated financial metrics:

Metric: Q4FY26 Q4FY25 FY26 FY25
Total Income: ₹3,063.3mn ₹3,533.8mn ₹11,080.0mn ₹10,783.0mn
EBITDA: ₹490.8mn ₹961.0mn ₹2,657.3mn ₹3,514.4mn
Profit Before Tax: ₹158.6mn ₹746.7mn ₹1,471.0mn ₹2,639.5mn
Profit After Tax: ₹122.3mn ₹537.5mn ₹1,054.1mn ₹1,621.4mn
Basic EPS (₹): 1.13 4.33 8.66 13.13

Standalone Performance

On a standalone basis, Archean Chemical's Q4FY26 total income stood at ₹3,047.1mn versus ₹3,333.3mn in Q4FY25. Standalone EBITDA for Q4FY26 came in at ₹664.0mn compared to ₹1,011.2mn in Q4FY25. Standalone PAT for Q4FY26 was ₹297.6mn, down from ₹583.1mn in Q4FY25. For the full year FY26, standalone total income was ₹10,887.5mn against ₹10,634.5mn in FY25, while standalone PAT stood at ₹1,543.7mn compared to ₹1,849.2mn in FY25.

Metric: Q4FY26 Q4FY25 FY26 FY25
Total Income: ₹3,047.1mn ₹3,333.3mn ₹10,887.5mn ₹10,634.5mn
EBITDA: ₹664.0mn ₹1,011.2mn ₹3,080.4mn ₹3,721.2mn
Profit Before Tax: ₹419.0mn ₹795.8mn ₹2,102.6mn ₹2,899.5mn
Profit After Tax: ₹297.6mn ₹583.1mn ₹1,543.7mn ₹1,849.2mn
Basic EPS (₹): 2.41 4.72 12.51 14.98

Subsidiary-wise Revenue Contribution

The consolidated performance was supported by strong growth from subsidiaries, particularly ACUME Chemicals, which reported total income of ₹830.5mn in FY26 versus ₹274.7mn in FY25, a growth of 202% year-on-year. The parent entity ACIL contributed ₹10,887.5mn in FY26, up 2% from ₹10,634.5mn in FY25. NEUN reported income of ₹5.2mn in FY26 against ₹2.7mn in FY25, a growth of 89%.

Entity: FY26 Total Income FY25 Total Income YoY Growth
ACIL: ₹10,887.5mn ₹10,634.5mn 2%
ACUME: ₹830.5mn ₹274.7mn 202%
IDEALIS: ₹17.0mn ₹0.5mn
NEUN: ₹5.2mn ₹2.7mn 89%
Consolidated Total Income: ₹11,740.2mn ₹10,912.4mn 8%

Silicon Carbide Semiconductor Facility: A Strategic Milestone

A key strategic development highlighted in the investor presentation is the progress on Archean's semiconductor ambitions. The company's subsidiary, SiCSem Private Limited, conducted a Bhoomi Pujan and Groundbreaking ceremony to establish an integrated Silicon Carbide (SiC)-based Compound Semiconductor fab and ATMP Unit in Info Valley, Bhubaneswar, Odisha. The facility has been approved by the Cabinet under the Indian Semiconductor Mission (ISM) and is positioned as the first commercial compound fab in the country. The project is being developed in collaboration with Clas-Sic Wafer Fab Limited, UK, in which Archean Chemical holds a 21% stake.

Parameter: Details
Entity: SiCSem Private Limited (step-down subsidiary of ACIL)
Product: Silicon Carbide (SiC) devices – MOSFETs and Power Devices
Annual Wafer Capacity: 60,000 wafers
Packaging Capacity: 96 million units
Location: Info Valley, Bhubaneswar, Odisha
Collaboration: Clas-Sic Wafer Fab Limited, UK (ACIL holds 21% stake)
End Users: Defence, EVs, Railway, Fast Chargers, Data Centres, Consumer Appliances, Solar Power Inverters

Consolidated Balance Sheet Highlights

As of March 26, consolidated total assets stood at ₹26,647.8mn compared to ₹23,890.3mn as of March 25. Shareholders' funds increased to ₹19,343.9mn from ₹18,640.1mn. Current borrowings rose significantly to ₹2,783.5mn from ₹264.7mn, contributing to an increase in current liabilities to ₹4,383.5mn from ₹1,972.8mn. Non-current borrowings declined to ₹1,266.7mn from ₹1,516.0mn over the same period. Cash and cash equivalents stood at ₹412.3mn as of March 26 versus ₹405.4mn as of March 25.

Balance Sheet Item: Mar-26 Mar-25
Total Assets: ₹26,647.8mn ₹23,890.3mn
Shareholders' Funds: ₹19,343.9mn ₹18,640.1mn
Non-Current Borrowings: ₹1,266.7mn ₹1,516.0mn
Current Borrowings: ₹2,783.5mn ₹264.7mn
Cash & Cash Equivalents: ₹412.3mn ₹405.4mn
Total Equity & Liabilities: ₹26,647.8mn ₹23,890.3mn

Historical Stock Returns for Archean Chemical Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-1.76%-5.57%-4.66%-7.48%-0.37%+28.12%

How will Archean Chemical manage its significantly elevated current borrowings of ₹2,783.5mn, and what is the repayment timeline that could further pressure profitability in FY27?

Given ACUME Chemicals' 202% revenue growth in FY26, which specific product segments or geographies are driving this expansion, and can this hypergrowth trajectory be sustained?

What is the expected capital expenditure timeline and funding structure for the SiCSem SiC semiconductor fab in Bhubaneswar, and how might it impact Archean's balance sheet over the next 3-5 years?

Archean Chemical Industries
View Company Insights
View All News
like16
dislike

Archean Chemical Industries Discloses Large Corporate Status Under SEBI Framework for FY26

1 min read     Updated on 12 May 2026, 05:58 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Archean Chemical Industries has disclosed to stock exchanges that it does not qualify as a Large Corporate under SEBI's framework. As of March 31, 2026, the company's total long-term bank loans stand at Rs. 77.43 cr, comprising Rs. 59.85 cr payable beyond one year and Rs. 17.58 cr payable within one year. CRISIL Limited has reaffirmed the company's credit rating at A-/Negative, with the outlook revised from 'Stable'. The disclosure was filed in accordance with SEBI circulars dated August 10, 2021, and October 19, 2023.

powered bylight_fuzz_icon
40091304

*this image is generated using AI for illustrative purposes only.

Archean Chemical Industries has filed a revised disclosure with the National Stock Exchange of India Limited and BSE Limited, formally stating that the company does not qualify as a Large Corporate as defined under the relevant SEBI circulars. The disclosure was made in reference to SEBI circular no. SEBI/HO/DDHS/P/CIR/2021/613 dated August 10, 2021, and SEBI/HO/DDHS/DDHS-RACPOD1/P/CIR/2023/172 dated October 19, 2023.

Large Corporate Disclosure Details

The filing provides a structured overview of the company's borrowing position and credit standing as mandated under the SEBI framework. The key particulars submitted by the company are outlined in the table below:

Parameter: Details
Name of the Company: Archean Chemical Industries Limited
CIN: L24298TN2009PLC072270
Outstanding Borrowing (as on March 31, 2026): Total long-term loan from banks is Rs. 77.43 cr (Rs. 59.85 cr payable beyond one year; Rs. 17.58 cr payable within one year)
Highest Credit Rating (Previous FY): CRISIL Limited: A-/Negative (Outlook revised from 'Stable', Rating Reaffirmed)
Stock Exchange for Fine (if applicable): NA

Borrowing Position and Credit Rating

As of March 31, 2026, Archean Chemical Industries' total long-term loan from banks amounts to Rs. 77.43 cr. Of this, Rs. 59.85 cr is classified as payable beyond one year, while Rs. 17.58 cr is due within one year. The company's highest credit rating during the previous financial year was assigned by CRISIL Limited, which reaffirmed the rating at A-/Negative, with the outlook revised from 'Stable'.

Regulatory Context

The disclosure was submitted on May 11, 2026, in compliance with SEBI's framework governing Large Corporates and their borrowing obligations. Since the company does not meet the threshold to be classified as a Large Corporate, the field pertaining to the stock exchange for payment of fines in case of borrowing shortfall has been marked as NA. The filing was signed by Vijayaraghavan N E, Company Secretary & Compliance Officer (M.No. A41671), and R Natarajan, Chief Financial Officer.

Historical Stock Returns for Archean Chemical Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-1.76%-5.57%-4.66%-7.48%-0.37%+28.12%

Given CRISIL's revision of Archean Chemical Industries' outlook from 'Stable' to 'Negative', what operational or financial triggers could lead to a further credit rating downgrade in the next 12-18 months?

How might Archean Chemical Industries' relatively modest borrowing level of Rs. 77.43 cr impact its ability to fund future capacity expansion or capital expenditure plans in the specialty chemicals sector?

Could the company's non-Large Corporate status limit its access to certain debt market instruments or institutional investors, and how might this affect its long-term capital structure strategy?

Archean Chemical Industries
View Company Insights
View All News
like17
dislike

More News on Archean Chemical Industries

1 Year Returns:-0.37%